Aldeyra Therapeutics Inc (NASDAQ: ALDX) Gets A 78.55% Target Price Upside From Analysts While 107.02% Above Its 52-Week Low
Aldeyra Therapeutics Inc (NASDAQ:ALDX) does about 1.81M shares in volume on a normal day but saw 783722 shares change hands in the recent trading day. The company now has a market cap of 141.35M USD. Its current market price is $2.36, marking a decrease of -2.48% compared to the previous close of $2.42. The 52 […]
Volatility Is Your Friend: Aldeyra Therapeutics Inc (ALDX) Is Hot Again
Aldeyra Therapeutics Inc (NASDAQ:ALDX) does about 1.80M shares in volume on a normal day but saw 1317725 shares change hands in the recent trading day. The company now has a market cap of 124.58M USD. Its current market price is $2.08, marking a decrease of -5.88% compared to the previous close of $2.21. The 52 […]
Aldeyra Therapeutics Inc (NASDAQ: ALDX) Now Has A Market Cap Nearing $125.78M But Is Projected To Reach $656.15 million By 2026
Aldeyra Therapeutics Inc (NASDAQ:ALDX) does about 1.65M shares in volume on a normal day but saw 4555993 shares change hands in the recent trading day. The company now has a market cap of 125.78M USD. Its current market price is $2.10, marking a decrease of -22.22% compared to the previous close of $2.70. The 52 […]
Aldeyra Therapeutics Inc (NASDAQ: ALDX): Think Like A Lender, Not An Investor
Aldeyra Therapeutics Inc (NASDAQ:ALDX) currently has a daily average trading volume of 1.58M but it saw 1708344 shares traded in last market. With a market cap of 162.31M USD, the company’s current market price of $2.71 came rising about 2.26 while comparing to the previous closing price of $2.65. In past 52 weeks, the stock […]
Stock That Is Worth Exploring Now: Aldeyra Therapeutics Inc (NASDAQ: ALDX)
Aldeyra Therapeutics Inc (NASDAQ:ALDX) does about 1.53M shares in volume on a normal day but saw 1374349 shares change hands in the recent trading day. The company now has a market cap of 158.83M USD. Its current market price is $2.66, marking an increase of 0.38% compared to the previous close of $2.65. The 52 […]
Can Buying Aldeyra Therapeutics Inc (NASDAQ: ALDX) Still Be Worthwhile?
Aldeyra Therapeutics Inc (NASDAQ:ALDX) does about 1.49M shares in volume on a normal day but saw 1116476 shares change hands in the recent trading day. The company now has a market cap of 133.75M USD. Its current market price is $2.24, marking an increase of 2.28% compared to the previous close of $2.19. The 52 […]
Investors Getting Picky When It Comes To Buying Aldeyra Therapeutics Inc (ALDX)
Aldeyra Therapeutics Inc (NASDAQ:ALDX) does about 1.36M shares in volume on a normal day but saw 2102353 shares change hands in the recent trading day. The company now has a market cap of 126.58M USD. Its current market price is $2.12, marking an increase of 10.99% compared to the previous close of $1.91. The 52 […]
Aldeyra Therapeutics Inc (NASDAQ: ALDX) Emerges As Guiding Light For Investors
Aldeyra Therapeutics Inc (NASDAQ:ALDX) currently has a daily average trading volume of 1.34M but it saw 1591706 shares traded in last market. With a market cap of 112.84M USD, the company’s current market price of $1.89 came falling about -2.58 while comparing to the previous closing price of $1.94. In past 52 weeks, the stock […]
Do Analysts Think Aldeyra Therapeutics Inc (ALDX) Is Still Worth Buying In 2025?
Aldeyra Therapeutics Inc (NASDAQ:ALDX) does about 1.17M shares in volume on a normal day but saw 4617643 shares change hands in the recent trading day. The company now has a market cap of 116.43M USD. Its current market price is $1.95, marking an increase of 3.17% compared to the previous close of $1.89. The 52 […]
Investors Are Waking Up To Aldeyra Therapeutics Inc (NASDAQ: ALDX) After Losing -60.00% Over The Past 12 Months
Aldeyra Therapeutics Inc (NASDAQ:ALDX) currently has a daily average trading volume of 618.97K but it saw 21987570 shares traded in last market. With a market cap of 84.79M USD, the company’s current market price of $1.42 came falling about -73.33 while comparing to the previous closing price of $5.32. In past 52 weeks, the stock […]